Price $128.27 |
Market Cap
6.04B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
57.4
|
P/B
9.01
|
P/S
6.67
|
Dividend %
-
|
|
P/CF
36.4
|
P/FCF
51.1
|
Op. Cash Flow
166.7K
|
FCF
2.3
|
|
Op. Margin
15.20%
|
Net Margin
11.80%
|
ROE
17.40%
|
ROI
9.60%
|
|
ROA
7.90%
|
EPS Growth
57.10%
|
Current Ratio
2.2
|
Debt/Equity
52.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | $36.27 | - | - | 50.9B | Strong Buy |
| Great Elm Group Inc (GEG) | $2.85 | - | - | 77.3M | Strong Buy |
| Harrow Health Inc (HROW) | $7.74 | - | - | 159.6M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.27 | - | - | 166.4M | Strong Buy |
| American Bio Medica Corporatio (ABMC) | $0.22 | - | - | 4.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
